WHO to Resume Hydroxychloroquine Trial, Tedros Says

The video discusses the temporary pause of the Hydroxychloroquine arm in a trial due to safety concerns. After reviewing mortality data, the committee found no need to change the trial protocol. The trial will continue, including the Hydroxychloroquine arm, with ongoing safety monitoring. Over 3500 patients have been recruited across 35 countries. The organization is committed to advancing therapeutics, vaccines, and diagnostics.

Why was the Hydroxychloroquine arm of the trial temporarily paused?

• To change the trial protocol

• To recruit more participants

• Because of safety concerns

• Due to a lack of funding

What did the Data Safety and Monitoring Committee recommend regarding the trial protocol?

• To halt the trial completely

• To modify the trial protocol

• That there are no reasons to modify the trial protocol

• To increase the dosage of Hydroxychloroquine

What action did the executive group take after receiving the committee's recommendation?

• They endorsed the continuation of all trial arms

• They decided to stop the trial

• They changed the trial's primary objective

• They reduced the number of trial participants

How many patients have been recruited for the trial so far?

• Over 1000

• Over 2000

• Over 3500

• Over 5000

What is the commitment of W Joy in relation to the trial?

• To delay the development of therapeutics

• To accelerate the development of effective therapeutics, vaccines, and diagnostics

• To focus solely on vaccine development

• To limit the trial to one country